Leerink Partners Initiates Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $5
Leerink Partners analyst Faisal Khurshid initiates coverage on $Ironwood Pharmaceuticals(IRWD.US)$ with a hold rating, and sets the target price at $5.According to TipRanks data, the analyst has a
Express News | Ironwood Pharmaceuticals Inc : Leerink Partners Initiates Coverage With Market Perform Rating; Target Price $5
Ironwood Pharmaceuticals, Inc. (IRWD): The Best Multibagger Penny Stock of 2025?
Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
Ironwood Pharmaceuticals Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains Overweight on Ironwood Pharmaceuticals, Lowers Price Target to $12